IRF4通过调控IKAROS和SYK调节慢性淋巴细胞白血病的BCR活化反应
本研究探讨IRF4在慢性淋巴细胞白血病(CLL)中对B细胞受体(BCR)刺激反应性的调控作用。通过转染IRF4载体或小干扰RNA沉默IRF4,发现IRF4水平升高可减弱BCR信号,而IRF4降低则增强BCR下游级联反应。IRF4负调控SYK和IKAROS表达,IKAROS通过抑制SHIP1促进BCR信号;IMIDs药物诱导IRF4并下调IKAROS,干扰BCR触发的生存优势。
要点
- IRF4水平升高减弱BCR信号,降低则增强BCR下游级联反应。
- IRF4负调控SYK和IKAROS表达,IKAROS通过抑制SHIP1促进BCR信号。
- IMIDs诱导IRF4并下调IKAROS,干扰BCR介导的生存优势。
核心结论
- IRF4通过负调控SYK和IKAROS表达来调节CLL细胞中BCR信号的强度。
研究设计与样本
- 通过转染IRF4载体或小干扰RNA调控CLL细胞中IRF4水平,并使用来那度胺和阿瓦度胺处理CLL细胞。
主要发现
- IRF4水平升高减弱BCR信号,表现为AKT和ERK磷酸化及钙释放减少;IRF4降低则增强BCR激活的胞内级联反应。
- IRF4负调控SYK和IKAROS表达;IKAROS通过抑制SHIP1促进BCR信号。
- IMIDs诱导IRF4表达并下调IKAROS,干扰BCR触发的生存优势,与依鲁替尼联用也有作用。
临床怎么用
- 低IRF4水平通过积累SYK和IKAROS促进BCR信号高效传导,提示IRF4可作为CLL中BCR信号调控的潜在靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Interferon regulatory factor 4 (IRF4) is a transcriptional regulator of immune system development and function. Here, we investigated the role of IRF4 in controlling responsiveness to B-cell receptor (BCR) stimulation in chronic lymphocytic leukemia (CLL). We modulated IRF4 levels by transfecting CLL cells with an IRF4 vector or by silencing using small-interfering RNAs. Higher IRF4 levels attenuated BCR signaling by reducing AKT and ERK phosphorylation and calcium release. Conversely, IRF4 reduction improved the strength of the intracellular cascade activated by BCR engagement. Our results also indicated that IRF4 negatively regulates the expression of the spleen tyrosine kinase SYK, a crucial protein for propagation of BCR signaling, and the zinc finger DNA-binding protein IKAROS. We modulated IKAROS protein levels both by genetic manipulation and pharmacologically by treating CLL cells with lenalidomide and avadomide (IMIDs). IKAROS promoted BCR signaling by reducing the expression of inositol 5-phosphatase SHIP1. Lastly, IMIDs induced IRF4 expression, while down-regulating IKAROS and interfered with survival advantage mediated by BCR triggering, also in combination with ibrutinib. Overall, our findings elucidate the mechanism by which IRF4 tunes BCR signaling in CLL cells. Low IRF4 levels allow an efficient transmission of BCR signal throughout the accumulation of SYK and IKAROS.
引用
- Maffei R, Fiorcari S, Benatti S, et al. IRF4 modulates the response to BCR activation in chronic lymphocytic leukemia regulating IKAROS and SYK. Leukemia. 2021. PMID: 33623139. doi:10.1038/s41375-021-01178-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。